Recursion Pharmaceuticals, Inc. (BMV:RXRX)
77.90
-4.70 (-5.69%)
At close: Jan 20, 2026
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of 40.29 billion as of January 21, 2026. Its market cap has decreased by -27.48% in one year.
Market Cap
40.29B
Enterprise Value
30.13B
Revenue
801.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.90
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from 101.17B to 40.29B, a decrease of -60.18%. That is a compound annual growth rate of -17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 42.99B | 12.17% |
| Dec 31, 2025 | 38.32B | -31.02% |
| Dec 31, 2024 | 55.56B | 53.86% |
| Dec 29, 2023 | 36.11B | 26.67% |
| Dec 30, 2022 | 28.51B | -51.96% |
| Dec 31, 2021 | 59.35B | -41.34% |
| Apr 16, 2021 | 101.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fideicomiso Irrevocable No. F/3277 en Banco Invex, S. A. Institución de Banca Múltiple, INVEX Grupo | 60.16B |
| Grupo Aeroméxico | 52.23B |
| Corporación Inmobiliaria Vesta | 45.66B |
| Fibra Danhos | 44.53B |
| Alsea | 42.80B |
| Fibra Mty, S.A.P.I. de C.V. | 37.05B |
| Grupo Lamosa | 35.36B |
| Grupo Profuturo | 34.21B |